{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:20:13Z","timestamp":1787754013186,"version":"build-2784847793"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12,5]]},"DOI":"10.2106\/jbjs.k.00774","type":"journal-article","created":{"date-parts":[[2012,12,10]],"date-time":"2012-12-10T15:14:43Z","timestamp":1355152483000},"page":"2113-2119","source":"Crossref","is-referenced-by-count":108,"title":["Denosumab Treatment in Postmenopausal Women with Osteoporosis Does Not Interfere with Fracture-Healing"],"prefix":"10.2106","volume":"94","author":[{"given":"Silvano","family":"Adami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Libanati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Boonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Ran","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethel","family":"Siris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"6","key":"bib1-20210131","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.bone.2009.07.086","article-title":"Direct healthcare costs of hip, vertebral, and non-hip, non-vertebral fractures","volume":"45","year":"2009 Dec","journal-title":"Bone."},{"issue":"6","key":"bib2-20210131","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s00198-010-1419-7","article-title":"Medical costs of osteoporosis in the elderly Medicare population","volume":"22","year":"2011 Jun","journal-title":"Osteoporos Int."},{"issue":"5","key":"bib3-20210131","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2165\/11531040-000000000-00000","article-title":"Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US","volume":"28","year":"2010","journal-title":"Pharmacoeconomics."},{"issue":"4","key":"bib4-20210131","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/jama.297.4.387","article-title":"Risk of subsequent fracture after low-trauma fracture in men and women","volume":"297","year":"2007 Jan 24","journal-title":"JAMA."},{"issue":"1","key":"bib5-20210131","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/ard.2008.092775","article-title":"Clinical subsequent fractures cluster in time after first fractures","volume":"68","year":"2009 Jan","journal-title":"Ann Rheum Dis."},{"issue":"3","key":"bib6-20210131","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11914-010-0023-2","article-title":"Timing of subsequent fractures after an initial fracture","volume":"8","year":"2010 Sep","journal-title":"Curr Osteoporos Rep."},{"issue":"17","key":"bib7-20210131","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/archinte.163.17.2052","article-title":"Low frequency of treatment of osteoporosis among postmenopausal women following a fracture","volume":"163","year":"2003 Sep 22","journal-title":"Arch Intern Med."},{"issue":"11","key":"bib8-20210131","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00198-003-1460-x","article-title":"The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies","volume":"14","year":"2003 Nov","journal-title":"Osteoporos Int."},{"issue":"4","key":"bib9-20210131","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","article-title":"Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis","volume":"15","year":"2000 Apr","journal-title":"J Bone Miner Res."},{"issue":"2","key":"bib10-20210131","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00198-003-1515-z","article-title":"Functional outcome and quality of life following hip fracture in elderly women: a prospective controlled study","volume":"15","year":"2004 Feb","journal-title":"Osteoporos Int."},{"issue":"3","key":"bib11-20210131","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1532-5415.1997.tb00941.x","article-title":"The economic cost of hip fractures in community-dwelling older adults: a prospective study","volume":"45","year":"1997 Mar","journal-title":"J Am Geriatr Soc."},{"issue":"13","key":"bib12-20210131","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1001\/archinte.162.13.1502","article-title":"Effect of fracture on the health care use of nursing home residents","volume":"162","year":"2002 Jul 8","journal-title":"Arch Intern Med."},{"issue":"5","key":"bib13-20210131","doi-asserted-by":"crossref","first-page":"278","DOI":"10.5435\/00124635-201005000-00004","article-title":"The role of the orthopaedic surgeon in minimizing mortality and morbidity associated with fragility fractures","volume":"18","year":"2010 May","journal-title":"J Am Acad Orthop Surg."},{"issue":"4","key":"bib14-20210131","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.injury.2007.10.035","article-title":"Pharmacological agents and impairment of fracture healing: what is the evidence?","volume":"39","year":"2008 Apr","journal-title":"Injury."},{"issue":"2 Suppl","key":"bib15-20210131","first-page":"S22","article-title":"Safety of bisphosphonates in the treatment of osteoporosis","volume":"122","year":"2009 Feb","journal-title":"Am J Med."},{"issue":"3","key":"bib16-20210131","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","year":"2005 Mar","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"bib17-20210131","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2165\/00002018-200932090-00002","article-title":"Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital","volume":"32","year":"2009","journal-title":"Drug Saf."},{"issue":"18","key":"bib18-20210131","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"HORIZON Recurrent Fracture Trial. Zoledronic acid and clinical fractures and mortality after hip fracture","volume":"357","year":"2007 Nov 1","journal-title":"N Engl J Med."},{"issue":"4","key":"bib19-20210131","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jhsa.2008.12.011","article-title":"Comparison of radiographic fracture healing in the distal radius for patients on and off bisphosphonate therapy","volume":"34","year":"2009 Apr","journal-title":"J Hand Surg Am."},{"issue":"8","key":"bib20-20210131","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s00198-010-1473-1","article-title":"HORIZON Recurrent Fracture Trial. Association between timing of zoledronic acid infusion and hip fracture healing","volume":"22","year":"2011 Aug","journal-title":"Osteoporos Int."},{"issue":"3","key":"bib21-20210131","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1359\/jbmr.2000.15.3.586","article-title":"The effect of alendronate on bone mass after distal forearm fracture","volume":"15","year":"2000 Mar","journal-title":"J Bone Miner Res."},{"issue":"3","key":"bib22-20210131","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00198-010-1411-2","article-title":"Oral bisphosphonates are associated with reduced mortality after hip fracture","volume":"22","year":"2011 Mar","journal-title":"Osteoporos Int."},{"issue":"9","key":"bib23-20210131","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1007\/s00198-010-1514-9","article-title":"Zoledronic acid results in better health-related quality of life following hip fracture: the HORIZON-Recurrent Fracture Trial","volume":"22","year":"2011 Sep","journal-title":"Osteoporos Int."},{"issue":"6","key":"bib24-20210131","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00198-008-0759-z","article-title":"The relation between bisphosphonate use and non-union of fractures of the humerus in older adults","volume":"20","year":"2009 Jun","journal-title":"Osteoporos Int."},{"issue":"6","key":"bib25-20210131","doi-asserted-by":"crossref","first-page":"367","DOI":"10.5435\/00124635-201006000-00009","article-title":"The orthopaedic implications of diphosphonate therapy","volume":"18","year":"2010 Jun","journal-title":"J Am Acad Orthop Surg."},{"issue":"6937","key":"bib26-20210131","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","year":"2003 May 15","journal-title":"Nature."},{"issue":"2","key":"bib27-20210131","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jocd.2008.02.002","article-title":"Clinical potential of RANKL inhibition for the management of postmenopausal osteoporosis and other metabolic bone diseases","volume":"11","year":"2008 Apr-Jun","journal-title":"J Clin Densitom."},{"issue":"6","key":"bib28-20210131","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1210\/jc.2007-2814","article-title":"Effects of denosumab on bone mineral density and bone turnover in postmenopausal women","volume":"93","year":"2008 Jun","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"bib29-20210131","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1359\/JBMR.040305","article-title":"A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women","volume":"19","year":"2004 Jul","journal-title":"J Bone Miner Res."},{"issue":"2","key":"bib30-20210131","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2008.04.007","article-title":"Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial","volume":"43","year":"2008 Aug","journal-title":"Bone."},{"issue":"3","key":"bib31-20210131","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/jbmr.251","article-title":"Effects of denosumab on bone turnover markers in postmenopausal osteoporosis","volume":"26","year":"2011 Mar","journal-title":"J Bone Miner Res."},{"issue":"8","key":"bib32-20210131","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Denosumab in postmenopausal women with low bone mineral density","volume":"354","year":"2006 Feb 23","journal-title":"N Engl J Med."},{"issue":"8","key":"bib33-20210131","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"FREEDOM Trial. Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","year":"2009 Aug 20","journal-title":"N Engl J Med."},{"issue":"8","key":"bib34-20210131","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/jbmr.403","article-title":"Effects of denosumab on fracture and bone mineral density by level of kidney function","volume":"26","year":"2011 Aug","journal-title":"J Bone Miner Res."},{"key":"bib35-20210131","first-page":"805","article-title":"Osteoporosis: management and densitometry for orthopaedic surgeons","volume":"58","year":"2009","journal-title":"Instr Course Lect."},{"issue":"1","key":"bib36-20210131","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2106\/JBJS.G.00682","article-title":"The American Orthopaedic Association\u2019s \u201cown the bone\u201d initiative to prevent secondary fractures","volume":"90","year":"2008 Jan","journal-title":"J Bone Joint Surg Am."},{"issue":"4","key":"bib38-20210131","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0736-0266(03)00011-1","article-title":"Effects of receptor activator of NFkappaB (RANK) signaling blockade on fracture healing","volume":"21","year":"2003 Jul","journal-title":"J Orthop Res."},{"issue":"4","key":"bib39-20210131","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s00223-004-0126-9","article-title":"Osteoprotegerin treatment impairs remodeling and apparent material properties of callus tissue without influencing structural fracture strength","volume":"76","year":"2005 Apr","journal-title":"Calcif Tissue Int."}],"container-title":["Journal of Bone and Joint Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004623-201212050-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:22:03Z","timestamp":1787750523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004623-201212050-00001"}},"subtitle":["Results from the FREEDOM Trial"],"short-title":[],"issued":{"date-parts":[[2012,12,5]]},"references-count":38,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.k.00774","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717962409.793465657","asserted-by":"object"}]},"ISSN":["0021-9355","1535-1386"],"issn-type":[{"value":"0021-9355","type":"print"},{"value":"1535-1386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,5]]}}}